P1127: FINAL ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI-CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DLBCL

P1127: FINAL ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI-CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DLBCL

Bibliographic Details
Main Authors:	Emma Verner, Amanda Johnston, Nalini Pati, Eliza Hawkes, Hui Peng Lee, Tara Cochrane, Chan Yoon Cheah, Robin Filshie, Duncan Purtill, Hanlon Sia, Anoop K Enjeti, Christina Brown, Nicholas Murphy, Jennifer Curnow, Kenneth Lee, Maher Gandhi, Belinda Butcher, Judith Trotman
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000971404.12997.4b

Similar Items

Synergistic effect of venetoclax and ibrutinib on ibrutinib-resistant ABC-type DLBCL cells
by: Fengbo Jin, et al.
Published: (2024-10-01)

Lenalidomide Consolidation Added to Rituximab Maintenance Therapy in Patients Remaining PET Positive After Treatment for Relapsed Follicular Lymphoma: A Phase 2 Australasian Leukaemia & Lymphoma Group NHL26 Study
by: Judith Trotman, et al.
Published: (2023-03-01)

CD16+ as predictive marker for early relapse in aggressive B-NHL/DLBCL patients
by: Sylvia Zöphel, et al.
Published: (2024-09-01)

Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib
by: Alexander P. Bye, et al.
Published: (2017-12-01)

Serpentine Supravenous Hyperpigmentation in an HIV Patient Receiving R-CHOP for DLBCL
by: Guido Lancman, et al.
Published: (2018-01-01)

Efficacy and safety of zanubrutinib plus R-CHOP in treatment of non-GCB DLBCL with extranodal involvement
by: Hongzhi Geng, et al.
Published: (2023-08-01)

Extranucleolar CYCLON Staining Pattern Is Strongly Associated to Relapse/Refractory Disease in R-CHOP–treated DLBCL
by: Antonin Bouroumeau, et al.
Published: (2021-07-01)

P1299: LOSS OF TYROSINE PHOSPHATASE SHP1 SENSITIZES DLBCL TO IBRUTINIB: A CANDIDATE PREDICTIVE BIOMARKER
by: Y. L. Wang, et al.
Published: (2022-06-01)

P1219: ZANUBRUTINIB, LENALIDOMIDE PLUS R-CHOP (ZR2-CHOP) AS THE FIRST-LINE TREATMENT FOR NON-GCB DIFFUSED LARGE B-CELL LYMPHOMA (DLBCL)
by: H. Zhu, et al.
Published: (2022-06-01)

PB2325: VALIDATION OF THE TRAIL SCORE TO PREDICT TOXICITY IN PATIENTS WITH DLBCL RECEIVING R-CHOP-LIKE THERAPY
by: Juan Carlos Caballero, et al.
Published: (2023-08-01)

PB2134: THE ROLE OF ADDITIONAL CARBOGEN GAS MIXTURE AND NICOTINAMIDE ON R-CHOP CHEMOTHERAPY IN DLBCL PATIENTS WITH TUMOR HYPOXIA
by: D. Rizky, et al.
Published: (2022-06-01)

Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study
by: Allison Barraclough, et al.
Published: (2024-03-01)

Miniature buildings in the Liao (907-1125) and the Northern Song (960-1127) periods
by: Chen, X
Published: (2011)

Australasian business statistics /
by: Black, Ken
Published: (2007)

Australasian business statistics /
by: Black, Ken
Published: (2013)

Explosives for Australasian engineers/
by: 360397 Gregory, Cedric Errol
Published: (1977)

Male gender is an independent predictor for worse survival and relapse in a large, consecutive cohort of elderly DLBCL patients treated with R‐CHOP
by: Eyre, T, et al.
Published: (2019)

P1196: ORIENT STUDY: REGIMEN OF ORELABRUTINIB PLUS R-CHOP-LIKE FOR PATIENTS WITH NEWLY DIAGNOSED UNTREATED NON-GCB DLBCL
by: Chang-Ju Qu, et al.
Published: (2023-08-01)

Australasian Journal of Plastic Surgery: first edition
by: Mark Lee, et al.
Published: (2018-03-01)

PB2301: OPTIMAL DOSE INTENSITY OF R-CHOP FOR PATIENTS WITH DLBCL AGED 80 YEARS OR OLDER: IS THE R-MINICHOP A GOLD STANDARD?
by: Hironao Nukariya, et al.
Published: (2023-08-01)

PB2362: THE EFFECT OF BODY MASS INDEX (BMI) ON THE PROGNOSIS OF DLBCL PATIENTS TREATED WITH R-CHOP: A REAL WORLD MOROCCAN EXPERIENCE
by: Imane Ait el Filali, et al.
Published: (2023-08-01)

The way and the glory: a study of Zhou Dunyi shrines in the southern song (1127–1279)
by: Ahn, T
Published: (2019)

Benign vascular tumors and vascular malformations in childhood: a retrospective analysis of 1127 cases
by: C Akyüz, et al.
Published: (1997-10-01)

1127 Optimal scanning conditions for whole-heart coronary MR angiography in clinical practice
by: Anno Hirofumi, et al.
Published: (2008-10-01)

Australasian Religion Index (ARI)
by: Daniel Kolb
Published: (2008-11-01)

PB2170: HIGH EXPRESSION OF AP2M1 CORRELATES WITH WORSE PROGNOSIS BY REGULATING IMMUNE MICROENVIRONMENT AND DRUG RESPONSE TO R-CHOP IN DLBCL
by: X.-D. Liu, et al.
Published: (2022-06-01)

DLBCL Coast to Coast
by: Melania Tesio
Published: (2018-02-01)

PB2128: CELL OF ORIGIN ACCORDING TO HANS LOGARITHM IS AN INDEPENDENT RISK FACTOR FOR DLBCL PATIENTS TREATED WITH R-CHOP: A REAL WORLD MOROCCAN EXPERIENCE
by: E. M. Mahtat, et al.
Published: (2022-06-01)

Proceedings (Australasian Institute of Mining and Metallurgy)
by: Australasian Institute of Mining and Metallurgy
Published: (1898)

Australasian conference on haet and mass transfer
Published: (19--)

Contemporary strategic management : an australasian perspective /
by: Grant, Robert M., 1948-
Published: (2011)

Collaborative research in Australasian plastic surgery
by: Guy HM Stanley, et al.
Published: (2021-09-01)

Breeding Ewe Lambs: An Australasian Perspective
by: Paul R. Kenyon, et al.
Published: (2022-11-01)

DUF1127-containing protein and ProQ had opposite effects on biofilm formation in Vibrio alginolyticus
by: Ruonan Feng, et al.
Published: (2024-09-01)

P1117: GLOFITAMAB PLUS R-CHOP OR POLATUZUMAB VEDOTIN-R-CHP IS DELIVERABLE AND YIELDS HIGH OVERALL RESPONSE IN PATIENTS <=65 YEARS OF AGE WITH HIGH-RISK DLBCL OR HGBL: INTERIM ANALYSIS OF THE COALITION STUDY
by: Adrian Minson, et al.
Published: (2023-08-01)

P1140: COMBINATION ANTI-PD1 ANTIBODY AND RITUXIMAB FOLLOWED BY R-CHOP FOR NEWLY DIAGNOSED DLBCL IN ELDERLY PATIENTS: ANALYSIS OF THE PHASE II TREND TRIAL
by: Yan Gao, et al.
Published: (2023-08-01)

Salivary Gland NHL – An FNAC–Flow Cytometry Study
by: Rashmi Gautam, et al.
Published: (2024-04-01)

Meta-analysis DLBCL database
by: Kazmi, F
Published: (2021)

وسائل الترفيه والتسلية ببلاد الشام في العصر الزنكي (521-581هـ / 1127-1185م)
by: عبد الملک ناظم عبد الله
Published: (2024-09-01)

Biancai (1011–1091) and his friends in the outside secular world: Longjing Monastery in the Northern Song (960–1127)
by: Tianyu Lei
Published: (2024-02-01)